SNDX filings
Corporate insider profile
Nicholas A.j. Botwood Filing Activity
Latest reported as Head of R&D, CMO of Syndax Pharmaceuticals Inc (SNDX).
- Purchase filings
- 0
- Reported companies
- 1
- Net open-market value
- -$1,183,639.85
- Latest transaction
- Jun 12, 2026
Affiliated corporations
Reported company relationships
Transaction history
